Literature DB >> 6736016

Purification and characterization of delta 4-3-ketosteroid 5 beta-reductase.

A Okuda, K Okuda.   

Abstract

delta 4-3-Ketosteroid 5 beta-reductase was purified about 230-fold from 100,000 X g supernatant of rat liver homogenate using 7 alpha-hydroxy-4-cholesten-3-one as substrate throughout. The purified enzyme was electrophoretically homogeneous, and its molecular weight determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis was 37,000 and that determined by gel filtration chromatography on calibrated Sephadex G-100 column was 37,200. The absorption spectrum of the purified enzyme showed only a peak at 276 nm due to aromatic amino acids, precluding the presence of a prosthetic group such as flavine in the molecule. The enzyme is highly labile in a low buffer concentration, but is markedly stabilized in the presence of 20% glycerol in 10 mM phosphate buffer. Higher buffer concentration such as 300 mM potassium phosphate buffer was also effective to prevent deterioration in the absence of glycerol, but the effect was somewhat lower compared to glycerol. The purified enzyme showed the activity toward a variety of substrates including testosterone, cortisol, cortisone, progesterone, 4-androstene-3,17-dione, 7 alpha-hydroxy-4-cholesten-3-one, and 7 alpha,12 alpha-dihydroxy-4-cholesten-3-one. The optimal pH for the 5 beta-reduction of 7 alpha-hydroxy-4-cholesten-3-one was 7.4, and the cofactor required for the reaction was NADPH, while NADH revealed no effect. The enzyme activity was inhibited by p-chloromercuribenzoate, but its inhibition was prevented by the presence of a reduced form of glutathione.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function.

Authors:  Rebekka Mindnich; Jason E Drury; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2010-12-24       Impact factor: 5.192

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol.

Authors:  Aicha Saadane; Natalia Mast; Casey D Charvet; Saida Omarova; Wenchao Zheng; Suber S Huang; Timothy S Kern; Neal S Peachey; Irina A Pikuleva
Journal:  Am J Pathol       Date:  2014-07-25       Impact factor: 4.307

Review 4.  Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes.

Authors:  Trevor M Penning; Phumvadee Wangtrakuldee; Richard J Auchus
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 5.  Sex steroids and potential mechanisms of non-genomic endocrine disruption in invertebrates.

Authors:  Gemma Janer; Cinta Porte
Journal:  Ecotoxicology       Date:  2007-02       Impact factor: 2.823

6.  Conversion of human steroid 5β-reductase (AKR1D1) into 3β-hydroxysteroid dehydrogenase by single point mutation E120H: example of perfect enzyme engineering.

Authors:  Mo Chen; Jason E Drury; David W Christianson; Trevor M Penning
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

7.  Evidence for the involvement of 3-oxo-delta 4 intermediates in ecdysteroid biosynthesis.

Authors:  C Blais; C Dauphin-Villemant; N Kovganko; J P Girault; C Descoins; R Lafont
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

8.  Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis.

Authors:  Luigi Di Costanzo; Jason E Drury; Trevor M Penning; David W Christianson
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

9.  Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1).

Authors:  Luigi Di Costanzo; Jason E Drury; David W Christianson; Trevor M Penning
Journal:  Mol Cell Endocrinol       Date:  2008-09-19       Impact factor: 4.102

Review 10.  5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1).

Authors:  Mo Chen; Trevor M Penning
Journal:  Steroids       Date:  2014-02-08       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.